Skip to main content
OpenTrials

Clinical trial condition

Gram-Positive Bacterial Infections

Explore clinical trials studying Gram-Positive Bacterial Infections. Study availability and eligibility vary by location and protocol.

2,601 public trials 262 recruiting studies
Refine in advanced search Browse all conditions

Gram-Positive Bacterial Infections trial results

Completed

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

NCT02270944

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • GSK Investigational Site Redding, California, United States
  • GSK Investigational Site Lenexa, Kansas, United States
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Stevensville, Michigan, United States
View Trial Details
Completed

Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection

NCT02581579

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations
  • Germans Trias I Pujol Hospital Badalona, Barcelona, Spain
  • Hospital Sant Joan de Déu Esplugues de Llobregat, Barcelona, Spain
  • Valle Hebron Hospital Barcelona, Spain
View Trial Details
Completed

Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults

NCT01755598

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • GSK Investigational Site Kisumu, Kenya
  • GSK Investigational Site Pretoria, Gauteng, South Africa
  • GSK Investigational Site Soweto, Gauteng, South Africa
  • GSK Investigational Site Klerksdorp, North West, South Africa
View Trial Details
Completed

Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children

NCT01027845

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Chiba, Japan
  • GSK Investigational Site Hiroshima, Japan
  • GSK Investigational Site Hiroshima, Japan
View all 16 locations
View Trial Details
Completed

Usability Study of IeHS in Indonesia

NCT04179344

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Adult, +27 more
Locations
  • Bekasi public hospital Bekasi, West Java, Indonesia
  • Padang Padang, West Sumatra, Indonesia
  • Jakarta Jakarta, Indonesia
View Trial Details
Completed

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

NCT02096263

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Daly City, California, United States
View all 43 locations
View Trial Details

Related conditions